Doctor Daniel Freitag

Dr Daniel Freitag is head of the Biomedical Data Science function at Bayer AG, Division Pharmaceuticals in Wuppertal, Germany. With his team, he is responsible for enabling data-driven decision making (e.g. through bespoke analysis of large-scale –omics and electronic health record data) across the Bayer Pharma portfolio, with a focus on cardiovascular indications. He has a strong research interest in human genetics and other large scale “-omics” disciplines, drug discovery & development and digital health, with the overall ambition of making a difference to patients. You can follow him on twitter: @FriTagDan.